Nkarta, Inc. (NKTX)
2.26
+0.04
(+1.80%)
USD |
NASDAQ |
Oct 09, 16:00
2.26
0.00 (0.00%)
After-Hours: 18:23
Nkarta Price : 2.26 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 2.25 | 2.26 | 2.16 | 2.22 | 721153.0 |
| Oct 07, 2026 | 2.26 | 2.335 | 2.25 | 2.27 | 566520.0 |
| Oct 06, 2026 | 2.55 | 2.55 | 2.295 | 2.31 | 754798.0 |
| Oct 05, 2026 | 2.57 | 2.57 | 2.45 | 2.53 | 522107.0 |
| Oct 02, 2026 | 2.60 | 2.625 | 2.52 | 2.575 | 366777.0 |
| Oct 01, 2026 | 2.59 | 2.67 | 2.545 | 2.56 | 402298.0 |
| Sep 30, 2026 | 2.65 | 2.69 | 2.55 | 2.62 | 283161.0 |
| Sep 29, 2026 | 2.68 | 2.68 | 2.53 | 2.62 | 524585.0 |
| Sep 28, 2026 | 2.75 | 2.785 | 2.67 | 2.67 | 810737.0 |
| Sep 25, 2026 | 2.86 | 2.86 | 2.725 | 2.75 | 681128.0 |
| Sep 24, 2026 | 2.72 | 2.89 | 2.585 | 2.85 | 933924.0 |
| Sep 23, 2026 | 2.91 | 2.99 | 2.615 | 2.76 | 1.091M |
| Sep 22, 2026 | 2.92 | 2.985 | 2.865 | 2.95 | 415563.0 |
| Sep 21, 2026 | 2.87 | 2.91 | 2.801 | 2.88 | 385793.0 |
| Sep 18, 2026 | 2.81 | 2.885 | 2.79 | 2.83 | 609743.0 |
| Sep 17, 2026 | 2.93 | 2.968 | 2.745 | 2.81 | 531498.0 |
| Sep 16, 2026 | 2.93 | 3.065 | 2.825 | 2.87 | 642152.0 |
| Sep 15, 2026 | 2.92 | 2.95 | 2.785 | 2.88 | 458385.0 |
| Sep 14, 2026 | 2.92 | 3.08 | 2.865 | 2.92 | 491726.0 |
| Sep 11, 2026 | 2.85 | 3.00 | 2.840 | 2.91 | 487412.0 |
| Sep 10, 2026 | 2.88 | 2.88 | 2.755 | 2.81 | 559278.0 |
| Sep 09, 2026 | 3.19 | 3.20 | 2.86 | 2.91 | 784605.0 |
| Sep 08, 2026 | 2.86 | 3.30 | 2.800 | 3.23 | 1.469M |
| Sep 04, 2026 | 2.77 | 2.93 | 2.75 | 2.92 | 447413.0 |
| Sep 03, 2026 | 2.77 | 2.885 | 2.71 | 2.79 | 730085.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.52 |
| Savara, Inc. | 4.925 |
| Vericel Corp. | 40.09 |
| Biogen, Inc. | 225.81 |
Price Related Metrics
| PEG Ratio | -0.2133 |
| Price to Book Value | 0.6534 |
| Earnings Yield | -69.92% |
| Market Cap | 161.87M |
| PEGY Ratio | -0.2133 |